Japan Tissue Engineering Co Ltd
TSE:7774
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
435
803
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Japan Tissue Engineering Co Ltd
Net Income (Common)
Japan Tissue Engineering Co Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Net Income (Common)
-¥70.5m
|
CAGR 3-Years
47%
|
CAGR 5-Years
18%
|
CAGR 10-Years
22%
|
|
|
GNI Group Ltd
TSE:2160
|
Net Income (Common)
¥7.2B
|
CAGR 3-Years
51%
|
CAGR 5-Years
117%
|
CAGR 10-Years
N/A
|
|
|
PeptiDream Inc
TSE:4587
|
Net Income (Common)
¥17.1B
|
CAGR 3-Years
40%
|
CAGR 5-Years
46%
|
CAGR 10-Years
64%
|
|
|
Takara Bio Inc
TSE:4974
|
Net Income (Common)
¥909m
|
CAGR 3-Years
-63%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-6%
|
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Net Income (Common)
¥3.3B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
101%
|
CAGR 10-Years
N/A
|
|
|
C
|
Cuorips Inc
TSE:4894
|
Net Income (Common)
-¥632.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Japan Tissue Engineering Co Ltd
Glance View
Japan Tissue Engineering Co., Ltd. engages in the research, development, and manufacture of cultured biological cells and tissues. The company is headquartered in Gamagori-Shi, Aichi-Ken and currently employs 200 full-time employees. The company went IPO on 2007-12-21. The firm operates its business in two segments. The TEP segment is engaged in the research and development of self-cultured epidermis, self-cultured cartilages and self-cultured corneal epithelium for medical institutions. The Research and Development Supports segment is engaged in the development, manufacture and sale of laboratory human cultured tissues based on tissue engineering technology and manufacturing know-how for cosmetic and pharmaceutical product manufacturers.
See Also
What is Japan Tissue Engineering Co Ltd's Net Income (Common)?
Net Income (Common)
-70.5m
JPY
Based on the financial report for Sep 30, 2024, Japan Tissue Engineering Co Ltd's Net Income (Common) amounts to -70.5m JPY.
What is Japan Tissue Engineering Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
22%
Over the last year, the Net Income (Common) growth was 78%. The average annual Net Income (Common) growth rates for Japan Tissue Engineering Co Ltd have been 47% over the past three years , 18% over the past five years , and 22% over the past ten years .
You don't have any saved screeners yet
